DAVID
NAVARRO ORTEGA
CATEDRÁTICO/A DE UNIVERSIDAD
Publications dans lesquelles il/elle collabore avec DAVID NAVARRO ORTEGA (75)
2024
-
Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination
Scientific reports, Vol. 14, Núm. 1, pp. 11896
-
Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis
The Lancet Microbe, Vol. 5, Núm. 1, pp. e43-e51
-
SARS-CoV-2 remodels the landscape of small non-coding RNAs with infection time and symptom severity
npj Systems Biology and Applications, Vol. 10, Núm. 1
2023
-
A machine learning model for predicting serum neutralizing activity against Omicron SARS-CoV-2 BA.2 and BA.4/5 sublineages in the general population
Journal of Medical Virology, Vol. 95, Núm. 4
-
A performance comparison of two (electro) chemiluminescence immunoassays for detection and quantitation of serum anti-spike antibodies according to SARS-CoV-2 vaccination and infections status
Journal of Medical Virology, Vol. 95, Núm. 1
-
Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individuals
Journal of medical virology, Vol. 95, Núm. 7, pp. e28900
-
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
Journal of Medical Virology, Vol. 95, Núm. 1
-
Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population
The Journal of infection
-
RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants
Clinical Microbiology and Infection, Vol. 29, Núm. 2, pp. 256.e1-256.e4
2022
-
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 279-284
-
Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19
Journal of Infection
-
Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents
Scientific reports, Vol. 12, Núm. 1, pp. 3788
-
Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 4, pp. 657-662
-
Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics
eLife, Vol. 11
-
RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status
Journal of Infection
-
SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination
Journal of Medical Virology, Vol. 94, Núm. 8, pp. 3776-3782
-
SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection
Journal of Medical Virology, Vol. 94, Núm. 9, pp. 4216-4223
-
SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2
Journal of Medical Virology, Vol. 94, Núm. 12, pp. 5836-5840
-
SARS-CoV-2-Spike Antibody and T-Cell Responses Elicited by a Homologous Third mRNA COVID-19 Dose in Hemodialysis and Kidney Transplant Recipients
Microorganisms, Vol. 10, Núm. 11
-
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 1, pp. e865-e868